Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts.

Eriko Sumi,Takashi Nomura,Ryuta Asada,Ryuji Uozumi,Harue Tada,Yoko Amino, Teruo Sawada,Atsushi Yonezawa,Masatoshi Hagiwara,Kenji Kabashima

Clinical drug investigation（2019）

引用 6|浏览17

暂无评分

摘要

The FIT039 patch showed no topical or systemic adverse reactions when applied on normal skin or cutaneous warts. The safety and good adherence of the FIT039 patch are encouraging and support further studies to evaluate the efficacy of FIT039 in patients with cutaneous warts.

查看译文

关键词

cutaneous warts,adhesive skin patch,cdk9,cyclin-dependent

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要